Literature DB >> 17580159

Sexual functioning after renal transplantation.

C Ozdemir1, M Eryilmaz, F Yurtman, T Karaman.   

Abstract

Sexual dysfunction (SD) is common among end-stage renal disease (ESRD patients). Studies about SD in the posttransplantation period have reported various results. The aim of this study was to investigate SD prevalence and relationship to sociodemographic and clinical variables. Sexual functioning was measured using the Arizona Sexual Experiences Scale (ASEX), and depression by the Beck Depression Inventory (BDI) in 98 patients. We observed that 68 patients (69.4%) had SD; the prevalence rates were 56.9% for men and 93.4% for women. ASEX item scores among single patients were higher than those among married patients. Subjects with SD were more depressed (P < .001) and less educated (for female patients, P = .02). These findings showed that SD is common in Turkish patients, especially women. SD patients should be integrated into routine examination throughout the transplant, process, and when needed, their treatment management should include education regarding sexual life complaints.

Entities:  

Mesh:

Year:  2007        PMID: 17580159     DOI: 10.1016/j.transproceed.2006.11.024

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Measurements of serum pituitary-gonadal hormones and investigation of sexual and reproductive functions in kidney transplant recipients.

Authors:  Guang-Chun Wang; Jun-Hua Zheng; Long-Gen Xu; Zhi-Lian Min; You-Hua Zhu; Jun Qi; Qiang-Lin Duan
Journal:  Int J Nephrol       Date:  2010-07-27

2.  Quality of life among women with sexual dysfunction undergoing hemodialysis: a cross-sectional observational study.

Authors:  Paulo Roberto Santos; José Roberto Frota Gomes Capote; Juliana Uchoa Cavalcanti; Cyntia Brito Vieira; Ana Rochelle Mesquita Rocha; Natália Alves Mineiro Apolônio; Elaine Barbosa de Oliveira
Journal:  Health Qual Life Outcomes       Date:  2012-08-31       Impact factor: 3.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.